The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen.
 
Sherry Shen
Honoraria - MJH Life Sciences
Research Funding - Merck (Inst); Sermonix Pharmaceuticals (Inst)
 
Sara Myers
No Relationships to Disclose
 
Natália Polidorio
Employment - Memorial Sloan-Kettering Cancer Center
Research Funding - CAPES-CNPq; NIH (Inst)
Travel, Accommodations, Expenses - Memorial Sloan-Kettering Cancer Center
 
Maria Bromberg
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Ryan Tan
Stock and Other Ownership Interests - Abbott Laboratories (I); AstraZeneca (I); Becton Dickinson (I); Edwards Lifesciences (I); Intuitive Surgical (I); Johnson & Johnson/MedTech (I); Johnson & Johnson/MedTech (I); Medtronic (I)
Honoraria - Novartis
Travel, Accommodations, Expenses - Merck
 
Nicholas Mai
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - IntegrityCE
Research Funding - Merck
Travel, Accommodations, Expenses - MJH Life Sciences
 
Nour Abuhadra
No Relationships to Disclose
 
Tiffany Traina
Consulting or Advisory Role - Aktis Oncology; AstraZeneca; BioNTech SE; Daiichi Sankyo; Ellipses Pharma; Exact Sciences; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Merck; Pfizer; Stemline Therapeutics; Tersera; Veracyte
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BioNTech SE (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Pfizer (Inst)
 
Stephanie Downs-Canner
No Relationships to Disclose
 
Neil Iyengar
Consulting or Advisory Role - AstraZeneca; BD Biosciences; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Novartis; Pfizer; Seagen; SynDevRx; Tersera
Research Funding - American Cancer Society (Inst); Breast Cancer Research Foundation (Inst); Conquer Cancer Foundation (Inst); National Cancer Institute (Inst); Novartis (Inst); SynDevRx (Inst)